Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.1370
-0.0131 (-8.73%)
At close: Feb 23, 2026, 4:00 PM EST
0.1408
+0.0038 (2.77%)
Pre-market: Feb 24, 2026, 9:08 AM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $7.63 million as of February 24, 2026. Its market cap has decreased by -89.03% in one year.
Market Cap
7.63M
Enterprise Value
-666.64K
1-Year Change
-89.03%
Ranking
Category
Stock Price
$0.14
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $7.63M, a decrease of -99.11%. That is a compound annual growth rate of -50.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 7.63M | -95.91% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 7.90M |
| XTL Biopharmaceuticals | 7.89M |
| Alzamend Neuro | 7.76M |
| Evogene | 7.67M |
| Edesa Biotech | 7.50M |
| Ernexa Therapeutics | 7.32M |
| BiomX | 7.25M |
| Mustang Bio | 7.22M |